Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration
A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations, potentially enabling mutation-agnostic gene therapies for diverse genetic diseases with fewer individualized edits. The post Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration appeared first on GEN - Genetic Engineering and Biotechnology News .
Prime assembly is a new genome engineering method that allows for precise, large-scale DNA integration into specific target positions within living cells. This innovative technique, published in Nature, leverages CRISPR-targeted dual flap synthesis to enable the insertion of long DNA fragments into programmable locations within cells.
Unlike traditional methods that rely on untargeted gene delivery or short DNA edits, prime assembly can handle single or double-stranded DNA fragments and is active in both dividing and non-dividing cells. By utilizing RNA-programmability, prime assembly excels at exon recoding, transgene integration, and even megabase-scale rearrangements, including therapeutic applications at crucial loci in primary human cells.
The method's single-step process involves writing in new DNA flaps at precise locations, which then act as tethers to bind matching DNA fragments. This targeted insertion approach significantly reduces the risk of off-target effects and toxicity compared to other gene editing methods. Prime assembly also avoids the use of DNA double strand breaks or donors, which can cause unwanted cell stress.
In contrast to other techniques that primarily affect dividing cells, prime assembly works effectively in nondividing cells as well. The researchers are now focused on further refining this technology to enhance its efficiency and precision, with the ultimate goal of realizing its potential in clinical applications. By correcting multiple mutations simultaneously, prime assembly could revolutionize the treatment of genetic disorders, offering a universal solution for restoring gene control in inherited diseases.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
